
|Articles|February 1, 2001
CME: Offering mifepristone as an abortion option
While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
2
Individualized TRT demonstrates broad symptom improvements beyond sexual function
3
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
4
Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says
5






